Global Acromegaly Treatment Market set to reach USD 839.0 Million by 2022

11-Dec-2017 | Zion Market Research

Zion Market Research has published a new report titled “Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Diagnosis Type (Medical Imaging and Medical Laboratory Test) and By Treatment Type (Drug Therapy, surgery and Radiation Therapy) : Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, global acromegaly treatment market was valued at approximately USD 665.0 Million in 2016 and is expected to generate revenue of around USD 839.0 Million by the end of 2022, growing at a CAGR of around 3.95% between 2017 and 2022.

Acromegaly is pituitary gland associated endocrine disorder caused by an increased level of growth hormone due to the tumor which leads to the abnormal growth of body and organs. There are various symptoms experienced by the patient like the protruded jaw, increased the size of limbs, the spacing between teeth of lower jaw and others. Conditions like hypertension, diabetes, enlarged heart, kidney failure, arthritis, and carpal tunnel syndrome worsen the condition of the patient. It is proved that in 90% acromegaly cases patient dies due to heart failure. This has increased the demand for better treatment options to cure the disease and increase the life expectancy for the patients of acromegaly. In most of the patients, surgical removal of pituitary gland reduces the level of growth hormones. But in some cases, if the tumor is not completely removed then, the patient has to undergo different sessions of radiation therapy to destroy the tumor cells completely. This disorder is primarily diagnosed by various symptoms and test like medical imaging and laboratory test for measuring glucose level, GH levels, and IGF-I levels are used to confirm the presence of the disease.

Request Sample Request Customization Buy Now

Browse the full " Acromegaly Treatment Market by Disease type (Ectopic Acromegaly and Pseudo Acromegaly), Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery, and Radiation Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 – 2022" report at

Factors driving the global acromegaly treatment market are high unmet needs in the developing countries and increased epidemiology for the disease due to increase in the tumor cases. Other major driving factors are an increase in the awareness about the disease and research & development for drug discovery to find the permanent cure for this disease. Several companies are investing time and money in R&D and clinical trials to develop the drug for treatment with permanent cure such as Ipsen, Novartis AG, and Pfizer Inc. Few drugs are in phases of clinical trials are expected to launch in the market after successful completion of a clinical trial such as BIM23B065 which is in clinical trial phase 2 and somatuline are in phase 3. Surgery and radiation therapies such as conventional radiation therapy and proton beam therapy have proved to be a helpful technique for the treatment of acromegaly.


The acromegaly treatment market is segmented on the basis of different disease types such as ectopic acromegaly and pseudo acromegaly. Pseudo acromegaly segment is expected to grow at fastest rate in the global acromegaly treatment market. On the basis of the diagnosis type global acromegaly treatment market is segmented into medical imaging and medical laboratory test. On the basis of the treatment type global acromegaly treatment market is segmented into surgery, drug therapy, and radiation therapy.

North America, Europe, Asia Pacific, Middle East & Africa, Latin America are the key regional segments of global acromegaly treatment market. North America is leading the market which is closely followed by Europe due to developed economies such as U.S., Canada, France, UK, Germany, Russia, Spain, and Italy is expected to support the growth of the market due to high economic growth. Asia Pacific is the third largest growing region in acromegaly treatment market and expected to grow moderately over the forecast period. The Middle East & Africa and Latin America are expected to show considerable growth over the forecast period.

Some of the key players in acromegaly treatment market include Pfizer Inc., Chiasma Inc., Novartis AG, Ipsen Biopharmaceuticals Inc., Wockhardt Ltd., Troikaa Pharmaceuticals Limited, VHB Life Sciences Limited, GlaxoSmithKline plc and few others.

This report segments the Global Acromegaly Treatment Market as follows:

Global Acromegaly Treatment Market: Disease Type Segment Analysis

  • Ectopic Acromegaly
  • Pseudo Acromegaly

Global Acromegaly Treatment Market: Diagnosis Type Segment Analysis

  • Medical Imaging
  • Medical Laboratory Test

Global Acromegaly Treatment Market: Treatment Type Analysis

  • Surgery
  • Drug Therapy
  • Radiation Therapy

Global Acromegaly Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States.

Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651


Download Brochure
Latest Published Reports

View All Published Reports